107) and have a lower utility
(e0.12 quality-adjusted life-years). The drivers of these results were the costs of the procedures and the incidence
of periprocedural complications. CAS was only cost effective among high-surgical risk patients.670
In the CREST, estimated net costs were $18,335 and
$13,276 for CAS and CEA, respectively.671 However, in
another